U.S. stocks top gainers: Lyell Immunopharma, Applied Digital, and Guidewire surge amid investor optimism
Discover why Lyell Immunopharma, Applied Digital, and other top U.S. stocks surged on June 4, 2025. Comprehensive market analysis inside. Read More
Zai Lab and Novocure’s TTFields therapy shows survival benefit in pancreatic cancer: PANOVA-3 results unveiled at ASCO 2025
Zai Lab and Novocure report TTFields improves survival in pancreatic cancer. Read how ASCO 2025 results could reshape the standard of care. Read More
Biotech and Argentina-linked stocks lead April 11 US market rebound amid volatility and tariff headwinds
Discover why biotech, energy, and Argentina-linked stocks soared on April 11, 2025, as US markets rebounded despite global tariff tensions. Read More
Zai Lab and Pfizer collaborate to address drug-resistant infections in China
Zai Lab and Pfizer have entered a partnership to commercialize XACDURO (sulbactam-durlobactam) in mainland China, addressing the rising threat of drug-resistant infections caused by carbapenem-resistant ... Read More
Zai Lab treats first patient in China in PANOVA-3 trial of TTFields
Zai Lab Limited said that it has treated the first patient in Greater China in the PANOVA-3 phase 3 clinical trial of tumor treating fields ... Read More
Five Prime Therapeutics and Zai Lab start Phase 3 study of bemarituzumab for advanced gastric cancer
California-based Five Prime Therapeutics and Chinese biopharma Zai Lab have initiated a pivotal Phase 3 trial of bemarituzumab (FPA144) in combination with chemotherapy for patients ... Read More